ArticleCancer science2016

Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?

Eri Banno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.